C-IU8NShift Bioscience
омоложение клеток, часы старения, siRNA therapeutics
reprogrammingrna therapeutic
Loading
Загрузка раздела...0-100 chain-logic scale · 15 dimensions · scored on public evidence
All companiesC-IU8N
C-IU8NC-IU8Nомоложение клеток, часы старения, siRNA therapeutics
0-100 chain-logic scale · 15 dimensions · scored on public evidence
Shift Bioscience омоложение клеток, часы старения, siRNA therapeutics
Shift Bioscience нацелена на первопричину возрастных заболеваний: aging cell. Ее платформа сочетает новый aging clock, AC4, с моделью virtual cell для выявления мишеней cellular aging и rejuvenation. Ее продуктовая программа включает SB101, anti-fibrotic siRNA therapeutic, предназначенный для обращения epigenetic aging clocks вспять в нескольких типах клеток, с первоначальными возможностями в области liver fibrosis.
The published score reflects a curated read of public evidence across 16 dimensions. Each dimension below shows the rationale we used. Disagree with a reading? Tell us where we are wrong
Higher up = higher Eternal Search score. Further right = closer to achieving real longevity outcomes (early mechanism → translational → near-term readout). Bubble size = capital deployed. Watch for MISMATCHES: big bubbles on the left are well-capitalized but far from goals; small bubbles on the right are doing more with less.
Shift Bioscience — Early mechanism · Bottom quartile. Derived deterministically from 8 extracted project(s). Most-advanced status: preclinical. Band: early_mechanism. Aging-relevance not LLM-reviewed in this pass.
Source: Deterministic